BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND PTPRK, DKFZp686C2268, 5796, ENSG00000152894, DKFZp779N1045, R-PTP-kappa, RP3-480J14_1
97073 results:

  • 1. Identification of restrictive molecules involved in oncolytic virotherapy using genome-wide CRISPR screening.
    Zhong Y; Le H; Zhang X; Dai Y; Guo F; Ran X; Hu G; Xie Q; Wang D; Cai Y
    J Hematol Oncol; 2024 May; 17(1):36. PubMed ID: 38783389
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Early diagnosis of melanoma: a randomized trial assessing the impact of the transmission of photographs taken with a smartphone from the general practitioner to the dermatologist on the time to dermatological consultation.
    Bouton C; Schmeltz H; Lévèque C; Gaultier A; Quereux G; Dreno B; Nguyen JM; Rat C
    BMC Health Serv Res; 2024 May; 24(1):660. PubMed ID: 38783296
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prospective associations of leucocyte subtypes and obesity with the risk of developing cutaneous malignant melanoma in the UK Biobank cohort.
    Christakoudi S; Tsilidis KK; Riboli E
    BMC Cancer; 2024 May; 24(1):625. PubMed ID: 38783251
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Safe Stop IPI-NIVO trial: early discontinuation of nivolumab upon achieving a complete or partial response in patients with irresectable stage III or metastatic melanoma treated with first-line ipilimumab-nivolumab - study protocol.
    Janssen JC; van Dijk B; de Joode K; Aarts MJB; van den Berkmortel FWPJ; Blank CU; Boers-Sonderen MJ; van den Eertwegh AJM; de Groot JWB; Jalving M; de Jonge MJA; Joosse A; Kapiteijn E; Kamphuis-Huismans AM; Naipal KAT; Piersma D; Rikhof B; Westgeest HM; Vreugdenhil G; Oomen-de Hoop E; Mulder EEAP; van der Veldt AAM
    BMC Cancer; 2024 May; 24(1):632. PubMed ID: 38783238
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Epidemiology of primary brain tumor among adolescents and adults in Palestine: a retrospective study from 2018 to 2023.
    Abuawad M; Daqour A; Alkaiyat A; Rjoub A; Zahra WA; Issa N; Dumaidi Y; Nasser S
    BMC Neurol; 2024 May; 24(1):168. PubMed ID: 38783212
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [The pathological characteristics and prognostic analysis of medullary thyroid microcarcinoma].
    Li DP; Zhang JM; Zhang YH; Hu LF; Gao Y; Wei SF; Zheng XQ
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1825-1830. PubMed ID: 38782750
    [No Abstract]    [Full Text] [Related]  

  • 7. Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma.
    Mørk SK; Skadborg SK; Albieri B; Draghi A; Bol K; Kadivar M; Westergaard MCW; Stoltenborg Granhøj J; Borch A; Petersen NV; Thuesen N; Rasmussen IS; Andreasen LV; Dohn RB; Yde CW; Noergaard N; Lorentzen T; Soerensen AB; Kleine-Kohlbrecher D; Jespersen A; Christensen D; Kringelum J; Donia M; Hadrup SR; Marie Svane I
    J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38782542
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Long-term outcome and fertility results of intraplacental choriocarcinoma: a retrospective study of 14 patients and literature review.
    Liu Y; Song X; Zhang H; Feng F; Zhao J; Yang J; Ren T; Wan X; Jiang F; Li Y; Xiang Y
    Orphanet J Rare Dis; 2024 May; 19(1):214. PubMed ID: 38778412
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Local intralesional talimogene laherparepvec therapy with complete local response in oral palatine mucosal melanoma: a case report.
    Chitnis SD; Seim NB; Kendra K
    J Med Case Rep; 2024 May; 18(1):257. PubMed ID: 38778387
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis/TMZ resistance in the mesenchymal subtype of glioblastoma.
    Zhao J; Cui X; Zhan Q; Zhang K; Su D; Yang S; Hong B; Wang Q; Ju J; Cheng C; Li C; Wan C; Wang Y; Zhou J; Kang C
    Theranostics; 2024; 14(7):2835-2855. PubMed ID: 38773970
    [No Abstract]    [Full Text] [Related]  

  • 11. Deformable registration of magnetic resonance images using unsupervised deep learning in neuro-/radiation oncology.
    Osman AFI; Al-Mugren KS; Tamam NM; Shahine B
    Radiat Oncol; 2024 May; 19(1):61. PubMed ID: 38773620
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Novel insights into rosacea's role in cancer risk: A Mendelian randomization approach.
    Luo M; Wei B
    Skin Res Technol; 2024 May; 30(5):e13737. PubMed ID: 38769705
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Targeting c-Myc transactivation by LMNA inhibits tRNA processing essential for malate-aspartate shuttle and tumour progression.
    Wang J; Hong M; Cheng Y; Wang X; Li D; Chen G; Bao B; Song J; Du X; Yang C; Zheng L; Tong Q
    Clin Transl Med; 2024 May; 14(5):e1680. PubMed ID: 38769668
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comparison of two region-of-interest placement methods for histogram analysis of apparent diffusion coefficient maps for glioma grading.
    Hieu ND; Hung ND; Hung ND; Hien MM; Anh DV; Dung LT
    Clin Ter; 2024; 175(3):128-136. PubMed ID: 38767069
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Characteristics and significance of programmed cell death-related gene expression signature in skin cutaneous melanoma.
    Wu X; Chen S; Ji Q; Chen H; Chen X
    Skin Res Technol; 2024 May; 30(5):e13739. PubMed ID: 38766879
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Mortality trend of cutaneous melanoma in Montenegro from 1990-2018.
    Nedovic Vukovic M; Terzic Z; Golubovic M; Bojic M; Bukumiric Z
    Eur Rev Med Pharmacol Sci; 2024 May; 28(9):3463-3472. PubMed ID: 38766804
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Retrospective evaluation of gestational trophoblastic disease - experience with ultrasounds.
    Gunenc O; Geyik Bayman M; Omeroglu E; Kulhan NG; Ates MC; Uğur Kilinc AN; Yildirim Ozturk EN
    Eur Rev Med Pharmacol Sci; 2024 May; 28(9):3455-3462. PubMed ID: 38766798
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Risk factor analysis and nomogram development and verification for medullary carcinoma of the colon using SEER database.
    Yang L; Yu L; Zhou Q; Liu L; Shen N; Li N
    Sci Rep; 2024 May; 14(1):11426. PubMed ID: 38763982
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A longer time to relapse is associated with a larger increase in differences between paired primary and recurrent IDH wild-type glioblastomas at both the transcriptomic and genomic levels.
    Ho WM; Chen CY; Chiang TW; Chuang TJ
    Acta Neuropathol Commun; 2024 May; 12(1):77. PubMed ID: 38762464
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. IDH1 mutation produces R-2-hydroxyglutarate (R-2HG) and induces mir-182-5p expression to regulate cell cycle and tumor formation in glioma.
    Zhao H; Meng L; Du P; Liao X; Mo X; Gong M; Chen J; Liao Y
    Biol Res; 2024 May; 57(1):30. PubMed ID: 38760850
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4854.